FDA 483 - Philips North America LLC - November 06, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Philips North America LLC in Bothell, WA, revealed significant quality system deficiencies. The firm was cited for inadequate documentation of corrective and preventive action activities, particularly concerning risk assessments for late regulatory reporting and delayed complaint processing, which was a repeat observation. Additionally, device history records for HeartStart HS1 and FRx Defibrillators were found to be incomplete, lacking required labeling information.
ID · 26742aad-485a-434d-837e-5e310835d6d4